HEALTHY EXTRACTS INC. 10-K

ITEM 5 - MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Our common stock is quoted on an unsolicited basis on the OTCQB tier of the marketplace maintained by OTC Markets Group, Inc. under the symbol “HYEX.” Our stock is piggyback qualified for broker-dealer quotations. Our common stock trades on a limited or sporadic basis and should not be deemed to constitute an established public trading market. There is no assurance that there will be liquidity in the common stock. The following table sets forth the high and low closing price for each quarter within the fiscal years ended December 31, 2022 and 2021, as provided by Nasdaq. The information reflects prices between dealers, and does not include retail markup, markdown, or commission, and may not represent actual transactions. Fiscal Year Ended December 31, Transaction Prices Period High Low 2023 First Quarter (through March 6, 2023) $0.059 $.036 2022 Fourth Quarter $0.070 $0.040 Third Quarter $0.071 $0.041 Second Quarter $0.076 $0.041 First Quarter $0.058 $0.031 2021 Fourth Quarter $0.108 $0.040 Third Quarter $0.139 $0.060 Second Quarter $0.080 $0.052 First Quarter $0.120 $0.040 The Securities Enforcement and Penny Stock Reform Act of 1990 requires additional disclosure relating to the market for penny stocks in connection with trades in any stock defined as a penny stock. The Commission has adopted regulations that generally define a penny stock to be any equity security that has a market price of less than $5.00 per share, subject to a few exceptions which we do not meet. Unless an exception is available, the regulations require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule explaining the penny stock market and the risks associated therewith. Holders As of March 29, 2023, there were 345,172,442 shares of our common stock issued and outstanding and held by approximately 115 holders of record, not including shares held in “street name” in brokerage accounts which is unknown. 45 Dividend Policy We have not paid any dividends on our common stock and do not expect to do so in the foreseeable future. We intend to apply our earnings, if any, in expanding our operations and related activities. The payment of cash dividends in the future will be at the discretion of the Board of Directors and will depend upon such factors as earnings levels, capital requirements, our financial condition and other factors deemed relevant by the Board of Directors. Securities Authorized for Issuance under Equity Compensation Plans We do not have any disclosure related to this item. Recent Issuance of Unregistered Securities Restricted Stock Units and Restricted Stock Awards On December 26, 2022, we approved the Healthy Extracts, Inc. 2022 Equity Incentive Plan and set aside 52,000,000 shares of our common stock for issuance thereunder. On December 26, 2022, we approved a total of 159,700 Restricted Stock Units at $0.01 per share and 36,000,000 Restricted Stock Awards with a strike price of $0.00 to $0.01 to a total of sixteen (16) individuals. The issuances were exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, there was no solicitation involved in the offerings, and the parties were either sophisticated or accredited. ITEM 6 – RESERVED As a smaller reporting company, we are not required to provide the information required by this Item.